Ashland Inc. (FRA:AHT)
Germany
· Delayed Price · Currency is EUR 49.80
0.00 (0.00%)
At close: Dec 5, 2025
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2014 - 2020 |
| United States Revenue | 464.00M |
Log In |
Log In |
Log In | Upgrade
|
| International Revenue | 1.36B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.82B |
Log In |
Log In |
Log In | Upgrade
|
Revenue
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2014 - 2020 |
| Life Sciences Revenue | 641.00M |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care Revenue | 577.00M |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives Revenue | 511.00M |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates Revenue | 137.00M |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Revenue | -42.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.82B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2014 - 2020 |
| Life Sciences Operating Income | -262.00M |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care Operating Income | 90.00M |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives Operating Income | -338.00M |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates Operating Income | 8.00M |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated and Other Operating Income | -273.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | -775.00M |
Log In |
Log In |
Log In | Upgrade
|
EBITDA
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2014 - 2020 |
| Life Sciences EBITDA | -187.00M |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care EBITDA | 155.00M |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives EBITDA | -254.00M |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates EBITDA | 21.00M |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated and Other EBITDA | -273.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -237.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | -775.00M |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2014 - 2020 |
| Change in Sales Due to Volume | -98.00M |
Log In |
Log In |
Log In | Upgrade
|
| Change in Sales Due to Product Pricing/Mix | -46.00M |
Log In |
Log In |
Log In | Upgrade
|